APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is handling a class action lawsuit against Applied Therapeutics, Inc. (NASDAQ: APLT) for alleged securities law violations between January 3, 2024, and December 2, 2024. The company is accused of making false statements and failing to follow proper clinical trial protocols for its drug candidate, govorestat, risking FDA rejection of its data. Shareholders who suffered losses can join the case by February 18, 2025.

CUBI Investors Have Opportunity to Lead Customers Bancorp, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm reminds investors of a class action lawsuit against Customers Bancorp, Inc. (NYSE: CUBI) for alleged violations of the Securities Exchange Act of 1934. The lawsuit claims Customers Bancorp issued false and misleading statements regarding its anti-money laundering procedures and regulatory compliance, leading to investor damages. Shareholders who purchased securities between March 1, 2024, and August 8, 2024, have until January 31, 2025, to participate as lead plaintiffs.

RETAIL OPPORTUNITY INVESTMENTS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Retail Opportunity Investments Corp. – ROIC

The law firm of Kahn Swick & Foti, LLC (KSF), led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating the proposed sale of Retail Opportunity Investments Corp. (ROIC) to Blackstone Inc. Under this agreement, ROIC shareholders would receive $17.50 per share in cash. KSF aims to assess if this price fairly values the company and whether the sales process was adequate.